Oxytocin receptor antagonists for inhibiting preterm labour-Reference-Cited by-同舟云学术

Oxytocin receptor antagonists for inhibiting preterm labour

Published:2014-06-06 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Flenady Vicki¹,Reinebrant Hanna E¹,Liley Helen G²,Tambimuttu Eashan G³,Papatsonis Dimitri NM⁴

Affiliation:

1. Mater Research Institute - The University of Queensland (MRI-UQ); Translating Research Into Practice (TRIP) Centre; Level 2 Aubigny Place, Mater Health Services Annerley Road, Woolloongabba Brisbane Queensland Australia 4102

2. Mater Mothers’ Hospital, Mater Research, The University of Queensland; South Brisbane Australia

3. Royal Brisbane and Women's Hospital; Department of Gynaecology Oncology/Obstetrics and Gynaecology; Butterfield Street, Herston Brisbane Queensland Australia 4006

4. Amphia Hospital Breda; Department of Obstetrics and Gynaecology; Langendijk 75 Breda Netherlands 4819 EV

Publisher

Wiley

Subject

Pharmacology (medical)

Reference97 articles.

1. Atosiban as a tocolytic agent: a new proposal of a therapeutic approach;Cabar;Revista Brasileira de Ginecologia y Obstetricia,2008

2. The oxytocin antagonist atosiban versus the ß-agonist terbutaline in the treatment of preterm labor: a randomized, double-blind, controlled study;The European Atosiban Study Group;Acta Obstetricia et Gynecologica Scandinavica,2001

3. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour;The Worldwide Atosiban versus Beta-antagonists Study Group;BJOG,2001

4. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol;French/Australian Atosiban Investigators Group;European Journal Obstetrics, Gynecology and Reproductive Biology,2001

5. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour;The Worldwide Atosiban versus Beta-antagonists Study Group;BJOG,2001

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preventing Preterm Birth;Clinics in Perinatology;2024-06

2. A historical narrative review through the field of tocolysis in threatened preterm birth;European Journal of Obstetrics & Gynecology and Reproductive Biology: X;2024-06

3. The oxytocin antagonist cligosiban reduces human prostate contractility: Implications for the treatment of benign prostatic hyperplasia;British Journal of Pharmacology;2024-04-27

4. Efficient administration of a combination of nifedipine and sildenafil citrate versus only nifedipine on clinical outcomes in women with threatened preterm labor: a systematic review and meta-analysis;BMC Pediatrics;2024-02-10

5. Investigating ticagrelor in a preclinical pipeline as a novel therapeutic to prevent preterm birth;Reproduction;2024-01-11